Antiplatelet Therapy and Anticoagulation before, during, and after Acute Coronary Syndrome

被引:2
|
作者
Kaufmann, Christoph C. [1 ,2 ]
Muthspiel, Marie [1 ,2 ]
Lunzer, Laura [1 ]
Pogran, Edita [1 ,2 ]
Zweiker, David [1 ]
Burger, Achim Leo [1 ,2 ]
Wojta, Johann [3 ,4 ,5 ]
Huber, Kurt [1 ,2 ,3 ]
机构
[1] Klin Ottakring Wilhelminenhosp, 3rd Med Dept Cardiol & Intens Care Med, A-1160 Vienna, Austria
[2] Sigmund Freud Univ, Fac Med, A-1020 Vienna, Austria
[3] Ludwig Boltzmann Inst Cardiovasc Res, A-1090 Vienna, Austria
[4] Med Univ Vienna, Core Facil, A-1090 Vienna, Austria
[5] Med Univ Vienna, Dept Internal Med 2, Div Cardiol, Waehringer Guertel 18-20, A-1090 Vienna, Austria
关键词
acute coronary syndrome; myocardial infarction; antiplatelet therapy; anticoagulation; antithrombotic therapy; ELEVATION MYOCARDIAL-INFARCTION; ATRIAL-FIBRILLATION; OPEN-LABEL; TICAGRELOR MONOTHERAPY; ANTITHROMBOTIC THERAPY; CARDIOVASCULAR EVENTS; PLATELET INHIBITION; DE-ESCALATION; INTERVENTION; CLOPIDOGREL;
D O I
10.3390/jcm13082313
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acute coronary syndrome (ACS) remains a major challenge in clinical practice, requiring rapid and effective antithrombotic treatment to mitigate adverse ischemic events while minimizing the risk of bleeding. In recent years, results from several clinical trials addressing this issue through various approaches have substantially improved the treatment landscape for patients presenting with ACS. The emergence of new, potent P2Y12 inhibitors has significantly enhanced thrombotic risk reduction and different strategies for de-escalating and shortening dual antiplatelet therapy (DAPT) have demonstrated promising outcomes in reducing bleeding rates. Furthermore, data from ongoing trials focusing on novel therapeutic agents and investigating alternative treatment strategies to optimize outcomes for ACS patients are expected in the next few years. In this review, we summarize the current knowledge and emphasize the critical role of individualized treatment approaches tailored to patient-specific risk factors and individual clinical scenarios.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Combined anticoagulation and antiplatelet therapy in patients after coronary stent implantation
    Sukhanov, VA
    Chernishov, SD
    Ioffin, AI
    THROMBOSIS AND HAEMOSTASIS, 1999, : 722 - 722
  • [22] DUAL ANTIPLATELET THERAPY AFTER CORONARY ARTERY BYPASS GRAFTING IN THE SETTING OF ACUTE CORONARY SYNDROME
    Agarwal, M.
    Bomb, R.
    Oliphant, C. S.
    Khouzam, R. N.
    CARDIOLOGY, 2016, 134 : 52 - 52
  • [23] Effect of Antiplatelet Therapy on Tissue Prolapse After Coronary Stunting in Patients With Acute Coronary Syndrome
    Naito, Kazuhiro
    Kurita, Akiyoshi
    Waseda, Katsuhisa
    Takashima, Hiroaki
    Ando, Hirohiko
    Suzuki, Akihiro
    Sakurai, Shinichiro
    Saka, Yuki
    Sawada, Hiroaki
    Shimoda, Masahiro
    Amano, Tetsuya
    CIRCULATION, 2017, 136
  • [24] Therapy strategies for acute coronary syndrome and after coronary interventions. Antiplatelet agents and anticoagulants
    Divchev, D.
    Nienaber, C.
    Ince, H.
    INTERNIST, 2011, 52 (11): : 1292 - 1300
  • [25] Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting in the Setting of Acute Coronary Syndrome
    Bomb, Ritin
    Oliphant, Carrie S.
    Khouzam, Rami N.
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 116 (01): : 148 - 154
  • [26] Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention
    Bagai, Akshay
    Bhatt, Deepak L.
    Eikelboom, John W.
    Mancini, G. B. John
    Cohen, Eric A.
    Vijayaraghavan, Ram
    Cheema, Asim N.
    Udell, Jacob A.
    Niznick, Joel
    Tanguay, Jean-Francois
    Verma, Subodh
    Mehta, Shamir R.
    CIRCULATION, 2016, 133 (21) : 2094 - 2098
  • [27] Strategies to Optimize Dual Antiplatelet Therapy After Coronary Artery Stenting in Acute Coronary Syndrome
    Paravattil, Bridget
    Elewa, Hazem
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2017, 22 (04) : 347 - 355
  • [28] Management of Antiplatelet Therapy After Coronary Artery Bypass Grafting in the Setting of Acute Coronary Syndrome
    Petricevic, Mate
    Boban, Marko
    Mihaljevic, Martina Z.
    Biocina, Bojan
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 116 (05): : 827 - 828
  • [29] Antiplatelet and anticoagulation therapy during percutaneous coronary interventions: A review for the interventionalist
    Basman, Craig
    Tariq, Afnan
    Parmar, Yuvrajsinh J.
    Asti, Deepak
    Coplan, Neil L.
    Singh, Varinder P.
    Reimers, Carl D.
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2018, 31 (05) : 693 - 704
  • [30] Duration of dual antiplatelet therapy in acute coronary syndrome
    Wilson, Simon John
    Newby, David E.
    Dawson, Dana
    Irving, John
    Berry, Colin
    HEART, 2017, 103 (08) : 573 - 580